Home > Boards > US Listed > Biotechs >

Baudax Bio Inc (BXRX)

BXRX RSS Feed
Add BXRX Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 3/4/2021 7:52:53 AM - Followers: 20 - Board type: Free - Posts Today: 0



Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. Its lead product candidate (in fact just  approved by FDA on the 07th of April) is intravenous form of meloxicam, a non-opioid that has completed Phase III clinical trials for the management of moderate to severe pain; and is in the Phase IIIb clinical trials in colorectal surgery and orthopedic surgery patients to assess opioid consumption, pain intensity, and length of hospital stay with associated pharmacoeconomic parameters. The company's early-stage product candidates includes RP1000, an intermediate-acting neuromuscular blocking agent (NMBA) that is in phase I clinical trial; and RP2000, an ultrashort-acting NMBA, which is in pre-clinical trial; and a reversal agent, as well as Dex-IN, a proprietary intranasal formulation of dexmedetomidine. The company was incorporated in 2019 and is based in Malvern, Pennsylvania.
 
<https://finviz.com/quote.ashx?t=BXRX&ty=c&p=d&b=1>
 
 
 
 
Received in February 2020 an NDA for their drug - ANJESO :
 
Présentation:
 
https://sec.report/Document/0001193125-20-043714/
 
ANJESO Is The Only Approved 24-Hour, Intravenous COX-2 Preferential NSAID that Offers Once-Daily Dosing
Full Commercial Launch Expected to Commence by June 2020
MALVERN, Pa., April 07, 2020 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that ANJESO™ (meloxicam) injection, the only 24-hour, intravenous (IV) COX-2 preferential non-steroidal anti-inflammatory drug (NSAID), is now available for ordering and delivery to customers.  ANJESO was approved by the U.S. Food and Drug Administration (FDA) on February 20, 2020 and is indicated for the management of moderate to severe pain, alone or in combination with other non-NSAID analgesics. 
 
 <https://finance.yahoo.com/news/baudax-bio-announces-u-availability-120010729.html>
 
We are diligently working to hire and train our field sales force and expect to execute the full ANJESO commercial launch by later in the 2nd quarter.”
 
 <https://finance.yahoo.com/news/baudax-bio-announces-u-availability-120010729.html>
 
Article on Anjeso:
 
https://www.biospace.com/article/baudax-bio-wins-fda-approval-for-anjeso-a-non-opioid-pain-treatment/
 
----------------
Raising capital for commercialization phase:
 
Cash (before warrants potential conversion at  $3.25 and $4.59) :
Raised $25M on March 24th 2020
Had $17M in cash as of Dec 31st 2019

Baudax Bio, Inc. (NASDAQ: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that, as part of its overall capital financing strategy to fund the Company and the upcoming commercial launch of ANJESO, it has signed a non-binding term sheet with an undisclosed party for a secured term loan for up to $20 million in non-dilutive funding over the next 12 to 18 months.

Baudax expects to close this debt financing transaction in the next 4 to 8 weeks.
 
 <https://sec.report/Document/0001193125-20-061374/>


Shares outstanding:
 
March 26, 2020 17.57M
 
 
 <https://ycharts.com/companies/BXRX/shares_outstanding
 
-------------
 
Reports:
------------
 
https://sec.report/Ticker/BXRX


Insider buying:

-------------------
 
CHURCHILL WINSTON J Director Mar 26 Buy 2.28 6,500 14,820 6,500 Mar 30 08:00 PM
CHURCHILL WINSTON J Director Mar 26 Buy 2.44 25,000 61,000 52,782 Mar 30 08:00 PM
Weisman Wayne Director Mar 26 Buy 2.29 10,000 22,900 40,582 Mar 27 03:53 PM
ALTOMARI ALFRED Director Mar 26 Buy 2.34 5,000 11,700 33,382 Mar 27 03:51 PM
 
 
 <https://finviz.com/quote.ashx?t=BXRX&ty=c&p=d&b=1>
 
 
 

--------------

 Analysts:

Janney starts Baudax Bio at buy; fair value estimate $12
https://biotuesdays.com/2019/11/22/janney-starts-baudax-bio-at-buy-fair-value-estimate-12/
 
Baudax’s key product is Anjeso, a long-acting intravenous formulation of meloxicam, an established non-opioid pain reliever, available through an oral formulation. “We see a high probability of FDA approval in the first quarter of 2020, which would be a meaningful catalyst to drive the stock towards our fair value,” writes analyst Ester Hong.
She estimates peak U.S. sales of $355-million for Anjeso but sees “upside from increased demand for a potent non-opioid that allows patients to recover and go home faster.”
 
 
BXRX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BXRX News: Baudax Bio to Present at the H.C. Wainwright Global Life Sciences Conference 03/02/2021 07:00:00 AM
BXRX News: Statement of Ownership (sc 13g) 02/16/2021 05:20:11 PM
BXRX News: Amended Statement of Ownership (sc 13g/a) 02/16/2021 09:44:13 AM
BXRX News: Securities Registration: Employee Benefit Plan (s-8) 02/16/2021 08:21:27 AM
BXRX News: Baudax Bio shares volatile on FY topline miss, Anjesco concerns 02/16/2021 08:19:59 AM
PostSubject
#135   How long does their cash last? mining101 03/04/21 07:52:53 AM
#134   kind of a shitty low quality call yesterday janeyH 02/17/21 07:50:29 AM
#133   Stonepine is out. BooDog 02/13/21 05:34:25 PM
#132   Had to know an offering was coming. BooDog 02/08/21 04:43:37 PM
#131   you've got the right name for today's action janeyH 02/08/21 04:03:31 PM
#130   Boom HeavenandHell 02/08/21 02:12:24 PM
#129   [/Baudax Bio is a pharmaceutical company focused on alwaysthankfull 01/19/21 01:42:41 PM
#128   Solid consolidating 1.20's to 1.30's. going to Deano361 01/13/21 09:11:49 PM
#127   10,000.......hehehe, 1.7 after market, Tomorrow we can hit Cubanwinner 01/12/21 08:14:01 PM
#126   BXRX1.40 yes you were right, hope you have some! swampboots 01/12/21 08:55:32 AM
#125   Hope this uptrend continues. HeavenandHell 01/11/21 07:45:19 PM
#124   Gap to $2.70 filling now , then to Deano361 01/06/21 12:56:48 PM
#123   Thank you! Perhaps hiring a sales force rwwine 12/15/20 11:37:30 AM
#122   I’ll write to the company today, Im curious Cubanwinner 12/15/20 11:31:33 AM
#121   time will dictated, rewards for patience investors.... Cubanwinner 12/10/20 11:25:26 PM
#120   End of year form 4's. Taking advantage. BooDog 12/10/20 06:29:22 AM
#119   Me and you only ones rooting for this swampboots 12/09/20 11:41:49 AM
#118   Yummy my order was filled up Cubanwinner 12/08/20 10:50:50 AM
#117   Adding more tomorrow at $1.15 Cubanwinner 12/07/20 07:55:47 PM
#116   Tie it UP!!!! $4.00 soon!! Cubanwinner 12/04/20 06:40:32 AM
#115   Well to me looks like the offering was Cubanwinner 12/03/20 06:32:51 PM
#114   BXRX 1.26 sucked to .97 since you wrote swampboots 12/03/20 01:09:24 PM
#113   Appreciate your response and thoughts on this very rwwine 11/01/20 07:35:02 PM
#112   Superficially most compelling idea I had for years, swampboots 10/31/20 06:40:16 PM
#111   Hi, curious if you believe this has an rwwine 10/31/20 09:03:12 AM
#110   BXRX: 2.79 start, OCT 1 change in code swampboots 09/29/20 02:02:06 PM
#109   A big run on no news interloper 09/02/20 02:26:21 PM
#108   BXRX 3.62 something to those signals. swampboots 09/02/20 11:39:09 AM
#107   BXRX 3.36 nice "tell". swampboots 09/02/20 09:55:45 AM
#106   BXRX 3 up from 2.71 low of day. swampboots 09/01/20 06:22:54 PM
#105   I'm a buyer under $4 trickledownfacists 06/30/20 10:17:08 AM
#104   Annnnnnd back down AH to 4.36 interloper 06/29/20 08:28:23 PM
#103   Up .40 AH interloper 06/29/20 06:50:32 PM
#102   Solid move trickledownfacists 06/27/20 05:14:20 PM
#101   $5 on Monday sushifishman 06/27/20 04:22:44 PM
#100   @Tickle Give it a look. sushifishman 06/25/20 08:30:41 AM
#99   You've peaked my interest... Cheers trickledownfacists 06/24/20 11:26:26 PM
#98   YESSS ! Make em cover a lot higher. Bill_ENG 06/24/20 10:39:20 PM
#97   KILL THE BXRX SHORTS! sushifishman 06/24/20 04:01:43 PM
#96   Great BXRX going to pile on some debt interloper 06/02/20 11:22:15 AM
#95   BXRX Steady March Up. Doubled my position at interloper 05/26/20 11:59:08 AM
#94   * * $BXRX Video Chart 05-15-2020 * * ClayTrader 05/15/20 03:59:28 PM
#93   BXRX up 35% today ! Sweet! interloper 05/15/20 02:28:25 PM
#92   Love it. pottsvision 04/30/20 01:44:59 PM
#91   Article Describing their sales preparations, 3 weeks old SuperDrive 04/30/20 09:01:07 AM
#90   Holding from 2.70 interloper 04/29/20 10:49:59 PM
#89   Baudax Bio, Inc. (BXRX) SuperDrive 04/29/20 12:28:44 PM
#88   Some nice power point slides there. I always Limey42 04/23/20 01:27:29 PM
#87   Some interesting info on Baudax Bio site published SuperDrive 04/23/20 12:00:13 PM
#86   Great data published today. Must-read. Could be a SuperDrive 04/23/20 08:01:04 AM
PostSubject
Consent Preferences